NEW YORK, Nov 29 – ProteinChip-maker Ciphergen Biosystems said Wednesday that it would collaborate with Johns Hopkins University School of Medicine to develop proteomic diagnostic tests for cancer.

Ciphergen will use its ProteinChip System to discover and validate protein biomarkers in cancer serum samples provided by Johns Hopkins. The university will also provide the clinical expertise of its physicians and scientists.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.